• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾前瞻性队列中从不吸烟者、轻度吸烟者和重度吸烟者的个性化风险评估。

Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan.

机构信息

Department of Epidemiology, and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Institute of Population Health Science, National Health Research Institutes, Zhunan, Taiwan.

出版信息

Sci Rep. 2016 Nov 2;6:36482. doi: 10.1038/srep36482.

DOI:10.1038/srep36482
PMID:27805040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5090352/
Abstract

The objective of this study was to develop markedly improved risk prediction models for lung cancer using a prospective cohort of 395,875 participants in Taiwan. Discriminatory accuracy was measured by generation of receiver operator curves and estimation of area under the curve (AUC). In multivariate Cox regression analysis, age, gender, smoking pack-years, family history of lung cancer, personal cancer history, BMI, lung function test, and serum biomarkers such as carcinoembryonic antigen (CEA), bilirubin, alpha fetoprotein (AFP), and c-reactive protein (CRP) were identified and included in an integrative risk prediction model. The AUC in overall population was 0.851 (95% CI = 0.840-0.862), with never smokers 0.806 (95% CI = 0.790-0.819), light smokers 0.847 (95% CI = 0.824-0.871), and heavy smokers 0.732 (95% CI = 0.708-0.752). By integrating risk factors such as family history of lung cancer, CEA and AFP for light smokers, and lung function test (Maximum Mid-Expiratory Flow, MMEF), AFP and CEA for never smokers, light and never smokers with cancer risks as high as those within heavy smokers could be identified. The risk model for heavy smokers can allow us to stratify heavy smokers into subgroups with distinct risks, which, if applied to low-dose computed tomography (LDCT) screening, may greatly reduce false positives.

摘要

本研究的目的是使用台湾的一个前瞻性队列 395875 名参与者,开发显著改善的肺癌风险预测模型。通过生成接收器工作曲线和估计曲线下面积(AUC)来衡量判别准确性。在多变量 Cox 回归分析中,年龄、性别、吸烟包年数、肺癌家族史、个人癌症史、BMI、肺功能测试以及癌胚抗原(CEA)、胆红素、甲胎蛋白(AFP)和 C-反应蛋白(CRP)等血清生物标志物被确定并纳入综合风险预测模型。总体人群的 AUC 为 0.851(95%CI=0.840-0.862),从不吸烟者为 0.806(95%CI=0.790-0.819),轻度吸烟者为 0.847(95%CI=0.824-0.871),重度吸烟者为 0.732(95%CI=0.708-0.752)。通过整合肺癌家族史、CEA 和 AFP 等风险因素用于轻度吸烟者,以及肺功能测试(最大中期呼气流量,MMEF)、AFP 和 CEA 用于从不吸烟者,可以识别出癌症风险与重度吸烟者相当的轻度和从不吸烟者。对于重度吸烟者的风险模型可以使我们将重度吸烟者细分为具有不同风险的亚组,如果应用于低剂量计算机断层扫描(LDCT)筛查,则可以大大减少假阳性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0665/5090352/6853a70c88bc/srep36482-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0665/5090352/bf828f3dc9d4/srep36482-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0665/5090352/467134125c14/srep36482-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0665/5090352/6853a70c88bc/srep36482-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0665/5090352/bf828f3dc9d4/srep36482-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0665/5090352/467134125c14/srep36482-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0665/5090352/6853a70c88bc/srep36482-f3.jpg

相似文献

1
Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan.台湾前瞻性队列中从不吸烟者、轻度吸烟者和重度吸烟者的个性化风险评估。
Sci Rep. 2016 Nov 2;6:36482. doi: 10.1038/srep36482.
2
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.基于循环蛋白生物标志物面板评估肺癌风险。
JAMA Oncol. 2018 Oct 1;4(10):e182078. doi: 10.1001/jamaoncol.2018.2078. Epub 2018 Oct 11.
3
Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study.终生吸烟史与肺癌风险:弗雷明汉心脏研究的结果。
J Natl Cancer Inst. 2018 Nov 1;110(11):1201-1207. doi: 10.1093/jnci/djy041.
4
Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes.高危人群中联合低剂量计算机断层扫描的癌胚抗原和细胞角蛋白 19 片段对肺癌的筛查价值:初步和 2 年筛查结果。
Lung Cancer. 2018 Aug;122:243-248. doi: 10.1016/j.lungcan.2018.05.012. Epub 2018 May 18.
5
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.与国家肺癌筛查试验中基线筛查检查阳性结果相关的因素。
Ann Am Thorac Soc. 2016 Sep;13(9):1568-74. doi: 10.1513/AnnalsATS.201602-091OC.
6
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.肺癌风险预测:前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验模型及其验证。
J Natl Cancer Inst. 2011 Jul 6;103(13):1058-68. doi: 10.1093/jnci/djr173. Epub 2011 May 23.
7
Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.当前吸烟量为20-29包年的人群的肺癌风险及人口统计学特征:对筛查的启示
J Natl Cancer Inst. 2015 Oct 19;107(11). doi: 10.1093/jnci/djv226. Print 2015 Nov.
8
Lung cancer risk by years since quitting in 30+ pack year smokers.30年烟龄以上、每天吸烟量超过一包的吸烟者戒烟后的肺癌风险(按戒烟年限划分)
J Med Screen. 2015 Sep;22(3):151-7. doi: 10.1177/0969141315579119. Epub 2015 Apr 29.
9
Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model.亚洲不吸烟女性肺癌发病预测:TNSF-SQ 预测模型
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):452-459. doi: 10.1158/1055-9965.EPI-19-1221. Epub 2019 Dec 17.
10
Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.前瞻性评估 C 反应蛋白、吸烟与第三次全国健康和营养调查中的肺癌死亡。
Int J Oncol. 2015 Oct;47(4):1537-44. doi: 10.3892/ijo.2015.3141. Epub 2015 Aug 31.

引用本文的文献

1
Lessons Learned From International Lung Cancer Screening Trials; People at Risk Deserve Screening for Early Detection.从国际肺癌筛查试验中吸取的经验教训;高危人群值得进行筛查以实现早期发现。
Respirology. 2025 Sep;30(9):802-816. doi: 10.1111/resp.70097. Epub 2025 Aug 14.
2
Low-Dose Computed Tomography Lung Cancer Screening for Individuals Who Have Never Smoked: A Review of Recent Updates in Taiwan and the United States.从未吸烟人群的低剂量计算机断层扫描肺癌筛查:台湾与美国近期进展综述
J Chest Surg. 2025 Sep 5;58(5):175-184. doi: 10.5090/jcs.25.017. Epub 2025 Aug 7.
3
Predictive performance of risk prediction models for lung cancer incidence in Western and Asian countries: a systematic review and meta-analysis.

本文引用的文献

1
The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening.英国肺癌筛查(UKLS):前 88897 例入组人群的人口学特征为人群筛查提供了建议。
Cancer Prev Res (Phila). 2014 Mar;7(3):362-71. doi: 10.1158/1940-6207.CAPR-13-0206. Epub 2014 Jan 17.
2
Circulating inflammation markers and prospective risk for lung cancer.循环炎症标志物与肺癌的前瞻性风险。
J Natl Cancer Inst. 2013 Dec 18;105(24):1871-80. doi: 10.1093/jnci/djt309. Epub 2013 Nov 18.
3
The contribution of risk prediction models to early detection of lung cancer.
西方国家和亚洲国家肺癌发病风险预测模型的预测性能:一项系统评价和荟萃分析。
Sci Rep. 2025 Mar 4;15(1):4259. doi: 10.1038/s41598-024-83875-6.
4
Urinary Metabolite Diagnostic and Prognostic Liquid Biopsy Biomarkers of Lung Cancer in Nonsmokers and Tobacco Smokers.非吸烟人群和吸烟人群肺癌尿液代谢物诊断和预后液体活检生物标志物
Clin Cancer Res. 2024 Aug 15;30(16):3592-3602. doi: 10.1158/1078-0432.CCR-24-0637.
5
Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening.癌症个人史作为第二原发性肺癌的危险因素:对肺癌筛查的影响。
Cancer Med. 2024 Mar;13(5):e7069. doi: 10.1002/cam4.7069.
6
Risk prediction models for lung cancer in people who have never smoked: a protocol of a systematic review.从不吸烟人群肺癌风险预测模型:一项系统评价方案
Diagn Progn Res. 2024 Feb 13;8(1):3. doi: 10.1186/s41512-024-00166-4.
7
[Construction of a Risk Prediction Model for Lung Cancer Based on Lifestyle Behaviors in the UK Biobank Large-Scale Population Cohort].基于英国生物银行大规模人群队列生活方式行为构建肺癌风险预测模型
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Sep;54(5):892-898. doi: 10.12182/20230960209.
8
Lung cancer risk score for ever and never smokers in China.中国的终身和从不吸烟者肺癌风险评分。
Cancer Commun (Lond). 2023 Aug;43(8):877-895. doi: 10.1002/cac2.12463. Epub 2023 Jul 6.
9
Lung Cancer Risk Prediction Nomogram in Nonsmoking Chinese Women: Retrospective Cross-sectional Cohort Study.非吸烟中国女性肺癌风险预测列线图:回顾性横断面队列研究。
JMIR Public Health Surveill. 2023 Jan 6;9:e41640. doi: 10.2196/41640.
10
Lung Cancer Absolute Risk Models for Mortality in an Asian Population using the China Kadoorie Biobank.亚洲人群中使用中国科控生物银行的肺癌死亡率绝对风险模型。
J Natl Cancer Inst. 2022 Dec 8;114(12):1665-1673. doi: 10.1093/jnci/djac176.
风险预测模型在肺癌早期检测中的作用。
J Surg Oncol. 2013 Oct;108(5):304-11. doi: 10.1002/jso.23384. Epub 2013 Aug 29.
4
Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.C反应蛋白与癌症风险之间的关联:前瞻性队列研究的荟萃分析
Asian Pac J Cancer Prev. 2013;14(1):243-8. doi: 10.7314/apjcp.2013.14.1.243.
5
Selection criteria for lung-cancer screening.肺癌筛查的选择标准。
N Engl J Med. 2013 Feb 21;368(8):728-36. doi: 10.1056/NEJMoa1211776.
6
Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?将全国肺癌筛查试验入选标准应用于美国人群:多少比例的人群和多少比例的新发肺癌将被涵盖?
J Med Screen. 2012 Sep;19(3):154-6. doi: 10.1258/jms.2012.012010. Epub 2012 Oct 11.
7
Hepatocellualar carcinoma serum markers.肝细胞癌血清标志物。
Semin Oncol. 2012 Aug;39(4):410-33. doi: 10.1053/j.seminoncol.2012.05.001.
8
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.美国胸外科学会使用低剂量计算机断层扫描对肺癌幸存者和其他高危人群进行肺癌筛查的指南。
J Thorac Cardiovasc Surg. 2012 Jul;144(1):33-8. doi: 10.1016/j.jtcvs.2012.05.060.
9
A risk model for lung cancer incidence.肺癌发病风险模型。
Cancer Prev Res (Phila). 2012 Jun;5(6):834-46. doi: 10.1158/1940-6207.CAPR-11-0237. Epub 2012 Apr 11.
10
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.癌胚抗原(CEA)作为肺癌的肿瘤标志物。
Lung Cancer. 2012 May;76(2):138-43. doi: 10.1016/j.lungcan.2011.11.012. Epub 2011 Dec 6.